ReiThera, Exothera to develop low cost per dose manufacturing process for delivering vaccines to LMICs - BSA bureau

ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and Middle-Income Countries

ReiThera Srl, an Italian biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and medicinal products for advanced therapies, and Exo… [+1724 chars]

full article...